![]() |
Page 1PATIENT INFORMATIONJANE DOE Age: 21 years |
||||||||||
PHYSICIANJOHN SMITH, M.D 1234 JOHN WAY CC: JACK SMITH M.D.
|
SPECIMEN INFORMATION
|
||||||||||
HISTORY |
MATURATION INDEX |
SPECIMEN SOURCE: CERVICAL/VAGINAL/1 THINPREP/1 ONESWAB Slide |
ESTROGEN EFFECT (HORMONAL PATTERN): COMPATIBLE WITH AGE AND/OR HISTORY. |
| PAP TEST RESULTS WITH IMAGER | Date Reported: 2/27/2008 |
NEGATIVE for intraepithelial lesion or malignancy. Endocervical cells or associated benign metaplastic cells present.
Pathologist: JOHN COMPAGNO M.D.,MEDICAL DIRECTOR
| CHLAMYDIA/GONORRHEA TEST RESULTS BY PCR | Date Reported: 2/26/2008 |
| Chlamydia | Negative |
| Gonorrhea | Negative |
Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR
| BACTERIAL VAGINOSIS PANEL BY RT-PCR | Date Reported: 2/27/2008 |
Gardnerella Vaginalis: Positive Excessive numbers of G. vaginalis organisms have been identified in this specimen strongly suggesting Bacterial Vaginosis. This patient is at risk for upper tract infection (PID, endometritis) as well as Preterm Delivery if pregnant. Please correlate these findings clinically. Treatment trials suggest that metronidazole or Clindamycin are effective options in both pregnant and non-pregnant status.
Mobiluncus Mulieris/Curtisii: Negative No evidence of excessive numbers of Mobiluncus organisms have been detected in this specimen.
Bacteroides Fragilis: Positive Excessive numbers of B. fragilis organisms have been identified in this specimen strongly suggesting Bacterial Vaginosis. This patient is at risk for upper tract infection (PID, endometritis) as well as Preterm Delivery if pregnant. Please correlate these findings clinically. Treatment trials suggest that metronidazole or Clindamycin are effective options in both pregnant and non-pregnant status.
Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR
This test was developed and its performance characteristics determined by Medical Diagnostic Laboratories, LLC, 2439 Kuser Road, Hamilton, NJ 08690. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
Note: For DNA Tests Supporting Documentation, see http://www.wcpl.com/dna_support_doc.asp |
Note: The following tests are available for 60 days post collection if specimen submitted as a ThinPrep®. Please call (800) 794-9737 for additional testing, if desired.
